[Case of Acanthamoeba keratitis].
Ishibashi
Y
Y
Matsumoto
Y
Y
Watanabe
R
R
Hommura
S
S
Yasuraoka
K
K
Ishii
K
K
Koyama
T
T
Endo
T
T
Yagita
K
K
D000048:Acanthamoeba; D000328:Adult; D000562:Amebiasis; D000818:Animals; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D017964:Itraconazole; D007634:Keratitis / Q000188:drug therapy / Q000209:etiology*; D007654:Ketoconazole / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D008297:Male; D008825:Miconazole / Q000008:administration & dosage / Q000627:therapeutic use
D000935:Antifungal Agents; D017964:Itraconazole; D008825:Miconazole; D007654:Ketoconazole